Literature DB >> 10333548

Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines.

R Bland1, C A Worker, B S Noble, L J Eyre, I J Bujalska, M C Sheppard, P M Stewart, M Hewison.   

Abstract

Studies in vitro and in vivo have shown that corticosteroids play an important role in bone physiology and pathophysiology. It is now established that corticosteroid hormone action is regulated, in part, at the pre-receptor level through the expression of isozymes of 11beta-hydroxysteroid dehydrogenase (11beta-HSD), which are responsible for the interconversion of hormonally active cortisol to cortisone. In this report we demonstrate 11beta-HSD activity in human osteoblast (OB) cells. Osteosarcoma-derived OB cell lines TE-85, MG-63 and SaOS-2 and fibrosarcoma Hs913T cells express the type 2 isoform of 11beta-HSD, as determined by reverse transcription polymerase chain reaction (RT-PCR) and specific enzyme assays. Enzyme activity was shown to be strictly NAD dependent with a Km of approximately 71 nM; 11beta-HSD type 1 mRNA expression and enzyme activity were not detected. All four cell lines expressed mRNA for the glucocorticoid receptor (GR) and mineralocorticoid receptor, but specific binding was only detectable with radiolabelled dexamethasone (Kd=10 nM) and not aldosterone. MG-63 cells had two to three times more GR than the other OB cells, which correlated with the higher levels of 11beta-HSD 2 activity in these cells. In contrast to the osteosarcoma cell studies, RT-PCR analysis of primary cultures of human OB cells revealed the presence of mRNA for 11beta-HSD 1 as well as 11beta-HSD 2. However, enzyme activity in these cells remained predominantly oxidative, i.e. inactivation of cortisol to cortisone (147 pmol/h per mg protein at 500 nM cortisol) was greater than cortisone to cortisol (10.3 pmol/h per mg protein at 250 nM cortisone). Data from normal human OB and osteosarcoma cells demonstrate the presence of an endogenous mechanism for inactivation of glucocorticoids in OB cells. We postulate that expression of the type 1 and type 2 isoforms of 11beta-HSD in human bone plays an important role in normal bone homeostasis, and may be implicated in the pathogenesis of steroid-induced osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333548     DOI: 10.1677/joe.0.1610455

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  13 in total

Review 1.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.

Authors:  John R Harrison; Henning W Woitge; Barbara E Kream
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

3.  Age and stage dependency of estrogen receptor expression by lymphocyte precursors.

Authors:  H Igarashi; T Kouro; T Yokota; P C Comp; P W Kincade
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Corticosterone influences gerbil (Meriones unguiculatus) prostatic morphophysiology and alters its proliferation and apoptosis rates.

Authors:  Julia Quilles Antoniassi; Ricardo Alexandre Fochi; Rejane Maira Góes; Patricia Simone Leite Vilamaior; Sebastião Roberto Taboga
Journal:  Int J Exp Pathol       Date:  2017-06-29       Impact factor: 1.925

5.  Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.

Authors:  D Jia; C A O'Brien; S A Stewart; S C Manolagas; R S Weinstein
Journal:  Endocrinology       Date:  2006-08-24       Impact factor: 4.736

6.  Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis.

Authors:  Lucia Mancini; Mark J Paul-Clark; Guglielmo Rosignoli; Robert Hannon; Jo E Martin; Ian Macintyre; Mauro Perretti
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

Review 7.  The impact of inflammation on bone mass in children.

Authors:  Wai W Cheung; Jian-Ying Zhan; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2011-01-01       Impact factor: 3.714

8.  Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.

Authors:  Nicola Cirillo; David J Morgan; Maria Carmela Pedicillo; Antonio Celentano; Lorenzo Lo Muzio; Michael J McCullough; Stephen S Prime
Journal:  Br J Cancer       Date:  2017-08-10       Impact factor: 7.640

9.  11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.

Authors:  C G Fenton; C L Doig; S Fareed; A Naylor; A P Morrell; O Addison; C Wehmeyer; C D Buckley; M S Cooper; G G Lavery; K Raza; R S Hardy
Journal:  Arthritis Res Ther       Date:  2019-08-16       Impact factor: 5.156

10.  Loss of 11βHSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinoma.

Authors:  Xu Liu; Xiao-Long Tan; Meng Xia; Chao Wu; Jia Song; Jing-Jing Wu; Arian Laurence; Qing-Guo Xie; Ming-Zhi Zhang; Hui-Fang Liang; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  Oncotarget       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.